Which has the lower trailing P/E, IDXX or MANH?

IDXX has the lower trailing P/E: IDXX trades at 35.74 and MANH at 57.83. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, IDXX or MANH?

Over the past five years, MANH grew revenue faster — IDXX at a 8.37% CAGR versus MANH at 12.69%.

Is IDXX or MANH more profitable?

IDXX runs the higher net margin — IDXX at 25.03% versus MANH at 18.67%.

How have IDXX and MANH total returns compared?

Over the past 10 years, IDXX delivered 16.50% and MANH delivered 13.30% annualized total return. Past performance doesn't predict future results.

IDEXX Laboratories, Inc. (IDXX) vs Manhattan Associates, Inc. (MANH)

A side-by-side comparison of IDEXX Laboratories, Inc. and Manhattan Associates, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

Different business models: IDXX is classified in Healthcare; MANH is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

IDXX

IDEXX Laboratories, Inc.

$39.81B

$504.70HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

MANH

Manhattan Associates, Inc.

$11.77B

$201.82TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — IDXX vs MANH

growth of $100 · dividends reinvested · last 10y

IDXX +362.4% (+16.5%/yr)MANH +233.0% (+12.8%/yr)IDXX compounded faster over this window

IDXX MANH

IDXX vs MANH: by the numbers

•IDXX is the larger company ($39.81B vs $11.77B market cap).
•IDXX trades at the lower trailing earnings multiple (35.74 vs 57.83 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (25.03% vs 18.67% net margin).
•MANH grew revenue faster over the past five years (12.69% vs 8.37% CAGR).

Metrics side by side

Valuation

Metric	IDXX	MANH
P/E ratio	35.74	57.83
Forward P/E	34.17	36.71
P/S ratio	8.74	10.45
P/B ratio	24.69	74.71
EV / EBITDA	25.24	41.45
FCF yield	3.14%	3.39%

Profitability

Metric	IDXX	MANH
Gross margin	62.45%	54.65%
Operating margin	32.03%	24.33%
Net margin	25.03%	18.67%
ROE	70.67%	133.48%
ROIC	41.33%	90.92%

Growth (annualized)

Metric	IDXX	MANH
Revenue CAGR (5Y)	8.37%	12.69%
EPS CAGR (5Y)	14.07%	21.59%
FCF CAGR (5Y)	12.49%	19.51%
Total return CAGR (5Y)	-5.77%	4.78%

Frequently asked

Which has the lower trailing P/E, IDXX or MANH?: IDXX has the lower trailing P/E: IDXX trades at 35.74 and MANH at 57.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, IDXX or MANH?: Over the past five years, MANH grew revenue faster — IDXX at a 8.37% CAGR versus MANH at 12.69%.
Is IDXX or MANH more profitable?: IDXX runs the higher net margin — IDXX at 25.03% versus MANH at 18.67%.
How have IDXX and MANH total returns compared?: Over the past 10 years, IDXX delivered 16.50% and MANH delivered 13.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IDXX analysis Full MANH analysis Interactive comparison tool

Dig into the metrics

IDEXX Laboratories P/E ratio Manhattan Associates P/E ratio IDEXX Laboratories ROE Manhattan Associates ROE IDEXX Laboratories operating margin Manhattan Associates operating margin IDEXX Laboratories revenue growth Manhattan Associates revenue growth IDEXX Laboratories free cash flow Manhattan Associates free cash flow

IDEXX Laboratories & Manhattan Associates appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.